-+ 0.00%
-+ 0.00%
-+ 0.00%

Cyclerion Therapeutics Q1 EPS $(0.76) Down From $(0.56) YoY

Benzinga·05/12/2026 21:32:24
Listen to the news
Cyclerion Therapeutics (NASDAQ:CYCN) reported quarterly losses of $(0.76) per share. This is a 35.71 percent decrease over losses of $(0.56) per share from the same period last year.